Stock·NASDAQ·Financial Services
Beeline Holdings Inc. (BLNE)
- Market cap
- $25.75M
- Dividend yield
- 0.00%
- Street target
- $4.50median of 1 analyst
- 52-week range
- $0.611 $3.75
The short version
Where BLNE stands today, in four lines, and what CleaRank Financial AI makes of it.
BLNE at a glance
Beeline Holdings Inc. (BLNE): Sell, 31/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($0.9452 and $1.73).
- Earnings BLNE beat estimates in 1 of its last 3 quarters, yet fell the next day after every one of them.
- Insiders Insiders bought $968K and made no open-market sales over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
Beeline Holdings Inc. (BLNE) carries a CleaRank rating of Sell and a model score of 31/100.
Revenue growth is the biggest support to that score: revenue grew 60.10%, 48.4 percentage points faster than the sector median. The trend is the biggest drag, with the price 54.75% below its 200-day average and 17.27% below its 50-day average, and the 50-day average 45.31% below the 200-day. Those averages sit at $0.9452 and $1.73, and over the past year the price fell 74.94%.
Only on CleaRank
Figures we compute ourselves from BLNE's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $0.782 is 17.3% below the 50-day simple moving average of $0.9452.Price above its 200-day average ›
The price is 54.8% below the 200-day simple moving average of $1.73.50-day average above the 200-day ›
The 50-day average ($0.9452) is 45.3% below the 200-day average ($1.73), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 5% of its 52-week range, between $0.611 and $3.75.
BLNE share price
Pick a period: each tab shows how far BLNE has moved over it, to the last close.
Today's trading
Where BLNE sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/S below the sector median ›
The price-to-sales ratio of 2.13 is 43.9% below the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $-22.8M on revenue of $10.8M, a net margin of -211.2%.Beat estimates in most recent reports ›
BLNE beat the EPS estimate in 1 of its last 3 reports.
Key statistics
The headline figures for BLNE.
As of October 17, 2026, BLNE trades at $0.782, with a market value of $25.75M and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of BLNE's valuation, growth and risks.
BLNE does not have a meaningful P/E, because the company lost money over the last 12 months (not meaningful on that basis). On sales, the P/S of 2.13 stands 43.9% below the sector median P/S of 3.8. Its market capitalisation is $25.7M.
BLNE is loss-making. Its net margin is -199.46%, its operating margin -155.48%, and its return on equity -40.12%, which is below the sector median of 13.8%. Revenue expanded 60.10% in the latest year, running 48.4 percentage points ahead of the Financial Services median of 11.7%. Debt-to-equity stands at 0.21.
BLNE's most recent quarterly report, dated August 14, 2026, showed adjusted EPS of -$0.14 versus an estimate of -$0.05. That is a miss of 180.00% against the estimate. In the first session after the report, the share price moved down 2.97%.
BLNE topped the EPS estimate in only 1 of its last 3 reports, and the share price still slipped in the first session after that beat. The sharpest earlier reaction followed the August 14, 2025 report, an EPS miss of 34.04% against the estimate, when the stock dropped 26.58%. Analysts' consensus EPS is -$0.01 for this fiscal year and $0.47 for the next.
On a typical day the price of BLNE shifts by 5.04%, the 30-day standard deviation of its daily returns. The downtrend is itself a risk for as long as the price stays under both moving averages. The price is 79.15% below its 52-week high of $3.75.
BLNE against the Financial Services sector
How BLNE compares with the median Financial Services stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, BLNE trades at 2.13x, -44% versus the sector average of 3.80x.
Return vs XLF: Since May 6, 2025, BLNE has lost 41.6% against a gain of 12.9% for XLF.
Performance against XLF
BLNE and the Financial Services sector fund over the same days.
Revenue and earnings
How much BLNE sells, and how much of it becomes profit.
Revenue growth: Revenue grew 109.6% in FY2025 to $8.2M, from $3.9M a year earlier.
Profit margin: The net margin was -285.1% in FY2025, up from -334.2% the year before.
Loss-making: BLNE lost $23.4M in FY2025.
Earnings reality check
Did BLNE beat what analysts expected, and how did the stock react?
Earnings record: BLNE beat the analyst estimate in 1 of the last 3 quarters.
Market reaction: The stock fell in the first session after 1 of those 1 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 14, 2026after close | -$0.05 | -$0.14 | -180.00% | -2.97% | +0.99% |
| Nov 14, 2025after close | -$0.24 | -$0.15 | +37.50% | -2.87% | -12.64% |
| Aug 14, 2025after close | -$0.47 | -$0.63 | -34.04% | -26.58% | -36.49% |
As of October 17, 2026, BLNE has beaten the analyst EPS estimate in 1 of its last 3 reported quarters and fell in the first trading session after it; its latest report, on August 14, 2026, came in 180.00% below the estimate and the stock moved -2.97% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 44.1, in neutral territory.RSI above 50 ›
An RSI of 44.1 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of BLNE
The score, the reasoning behind it, and what could move the price next.
Beeline Holdings Inc. (BLNE) changes hands at $0.782, sitting beneath both of its principal moving averages. The price is 17.27% below its 50-day average of $0.9452 and 54.75% below its 200-day average of $1.73. Its position in the 52-week range is 5%: the price is 27.99% above the 52-week low of $0.611. Both averages point the same way, with the 50-day sitting 45.31% below the 200-day.
The price is down over each of these periods: 21.01% over the past month, 16.81% over the past three months and 74.94% over the past year. The price rose 11.55% in the last session on volume 262.5% above its average. On momentum, the 14-day RSI reads 44.1, in the neutral zone, with the MACD line negative.
No rewards flagged.
Earnings miss ›
The August 14, 2026 report missed the EPS estimate by 180.00%, and the share price fell 2.97% in the first session after it.
Source: Earnings report, August 14, 2026
- The two closest levels to monitor are the 20-day EMA at $0.8017, just above the price, and the 52-week low at $0.611, below it.
- A 14-day RSI of 44.1 is neutral, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- The share price declined 2.97% in the first session after the August 14, 2026 report. BLNE has beaten estimates in 1 of the last 3 reports.
BLNE stays in a downtrend while it trades under both its 50-day average of $0.9452 and its 200-day average of $1.73. A close back above the 50-day average would be the first sign of a repair. Overhead, the 20-day EMA at $0.8017 is the first barrier a rally would meet.
Below the price, the 52-week low of $0.611 is the next level a decline would reach. The 14-day RSI reads 44.1, which places it in the neutral zone between 40 and 60.
Technical indicators
Momentum and trend for BLNE, from its daily closes.
As of October 17, 2026, with BLNE at $0.782, its 14-day RSI is 44.1 (neutral territory), its 50-day simple moving average is $0.9452 and its 200-day is $1.73.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What BLNE moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, BLNE's 1-year correlation of daily returns is +0.11 with S&P 500 (SPY), +0.11 with Nasdaq 100 (QQQ), +0.31 with Bitcoin (BTC) and +0.16 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/2Most analysts rate it a buy ›
1 of 1 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $4.50 is 475.4% above the price.
BLNE Wall Street View
12-month price targets
The price, $0.782, sits below every analyst's target.
Ratings
As of October 17, 2026, 1 Wall Street analysts cover BLNE: 1 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $4.50 to $4.50, with a median of $4.50, 475.4% above the price of $0.782.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
BLNE trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
BLNE moves about 5.0% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much BLNE tends to move, against the market and on its own.
The long record
BLNE's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 5.04% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 100.0%, from June 2018 to October 2026; the price is still 100.0% below that peak.Most 1-year holds ended higher ›
23% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in January 2017 is now worth $6.68, against $39,423 in the S&P 500 (SPY).
BLNE Drawdowns & Recovery
As of October 17, 2026, BLNE's worst peak-to-trough fall over the last 10 years with dividends reinvested was -100.0% (June 2018 to October 2026); it is still 100.0% below that peak, and 23% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into BLNE in January 2017 is worth now, against the same amount in the S&P 500.
Against the market: BLNE trailed the S&P 500 over this period: $6.68 against $39,423.
A $10,000 investment in BLNE in January 2017 would be worth about $7 today with dividends reinvested, compared with about $39,423 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to BLNE, and which have not.
Strongest month, June: an average of +6.51%, up in 6 of 10 years.
Weakest month, March: an average of -18.75%, up in 1 of 10 years.
This month, October: has averaged -1.14%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, BLNE's strongest calendar month has been June (average +6.51%, up in 6 of 10 years) and its weakest March (average -18.75%, up in 1 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in BLNE, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in BLNE today could grow to about $2,852 by 2036 in the base case, with a 90th-percentile outcome near $21,635 and a 10th-percentile outcome around $376. Projections are statistical simulations, not guarantees.
BLNE Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $0.4734 for BLNE by 2030 in the base case, from $0.782 today (0.6x over 4 years). The 10th-percentile path ends near $0.1314. These are outcomes of a Monte Carlo simulation run on BLNE's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $0.3634 | $0.6898 | $1.31 | |
| 2028 | $0.2458 | $0.6085 | $1.51 | |
| 2029 | $0.1769 | $0.5367 | $1.63 | |
| 2030 | $0.1314 | $0.4734 | $1.71 | |
| 2031 | $0.09965 | $0.4176 | $1.75 |
Method: a lognormal simulation of BLNE's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
BLNE insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $968K on the open market.
As of October 17, 2026, BLNE insiders reported no open-market sales and 25 open-market purchases worth $968K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 148.9K | $152.3K |
| Sep 8, 2026 | Joseph Stevens Caltabiano
Director
|
Grant | 50.0K | - |
| Sep 8, 2026 | Francis P Knuettel II
Director
|
Grant | 50.0K | - |
| Sep 8, 2026 | Michael Romano Stephen
Director
|
Grant | 50.0K | - |
| Sep 1, 2026 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 96.0K | $98.9K |
| Aug 31, 2026 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 267.5K | $261.9K |
| Aug 19, 2026 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Option | 333.3K | $500.0K |
| Jul 22, 2026 | Joseph Stevens Caltabiano
Director
|
Grant | 8.9K | - |
| Jun 30, 2026 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Grant | 31.1K | $38.0K |
| May 29, 2026 | Michael Romano Stephen
Director
|
Grant | 40.0K | - |
| May 28, 2026 | Joseph Stevens Caltabiano
Director
|
Grant | 10.0K | - |
| May 28, 2026 | Joseph David Freedman
Director
|
Grant | 10.0K | - |
| May 28, 2026 | Francis P Knuettel II
Director
|
Grant | 10.0K | - |
| May 19, 2026 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 51.5K | $53.6K |
| May 19, 2026 | Tiffany Milton
Officer
|
Buy | 15.0K | $15.3K |
| May 19, 2026 | Christopher R. Moe
Chief Financial Officer
|
Buy | 10.0K | $10.4K |
| Apr 8, 2026 | Joseph David Freedman
Director
|
Grant | 7.0K | - |
| Dec 16, 2025 | Francis P Knuettel II
Director
|
Grant | 30.0K | - |
| Nov 26, 2025 | Joseph David Freedman
Director
|
Buy | 1.0K | $1.9K |
| Nov 21, 2025 | Joseph David Freedman
Director
|
Buy | 3.0K | $4.4K |
| Nov 19, 2025 | Joseph David Freedman
Director
|
Buy | 7.0K | $11.3K |
| Nov 19, 2025 | Christopher R. Moe
Chief Financial Officer
|
Buy | 20.0K | $33.6K |
| Oct 10, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Option | 2.3M | $3.9M |
| Oct 2, 2025 | Joseph Stevens Caltabiano
Director
|
Grant | 129.0K | - |
| Oct 2, 2025 | Eric Jon Finnsson
Director
|
Grant | 88.9K | - |
| Oct 2, 2025 | Knuettel Francis II
Director
|
Grant | 40.0K | - |
| Oct 2, 2025 | Joseph David Freedman
Director
|
Grant | 188.0K | - |
| Oct 2, 2025 | Francis P Knuettel II
Director
|
Grant | 40.0K | - |
| Oct 2, 2025 | Michael Romano Stephen
Director
|
Grant | 76.5K | - |
| Sep 25, 2025 | Joseph David Freedman
Director
|
Buy | 10.0K | $42.2K |
| Sep 3, 2025 | Tiffany Milton
Officer
|
Buy | 10.0K | $15.9K |
| Sep 3, 2025 | Christopher R. Moe
Chief Financial Officer
|
Buy | 20.0K | $32.8K |
| Jun 17, 2025 | Joseph David Freedman
Director
|
Buy | 50.0K | $34.0K |
| Jun 13, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 113.5K | $74.9K |
| May 22, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 28.3K | $33.2K |
| May 16, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 10.6K | $13.4K |
| May 8, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 2.8K | $3.9K |
| May 5, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 5.1K | $7.3K |
| May 2, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 18.2K | $25.2K |
| May 1, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 14.5K | $21.1K |
| Apr 29, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 3.4K | $5.1K |
| Apr 25, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 3.5K | $5.0K |
| Apr 23, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 3.7K | $5.1K |
| Apr 22, 2025 | Nicholas Reyland Liuzza Jr
Chief Executive Officer
|
Buy | 3.9K | $5.0K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.